iBio, Inc. (NYSE American: IBIO) has partnered with the National Institute of Allergy and Infectious Diseases (NIAID) to explore the potential of the company's AI-driven epitope steering platform in developing a vaccine for Lassa fever, a severe and sometimes deadly viral disease prevalent in West Africa. 

This collaboration aims to address the absence of a preventive vaccine for Lassa fever, offering hope for the affected regions.

In the after-hours trading session, $IBIO witnessed a significant surge of $0.23 (+30.95%), reaching $0.95 and reflecting the positive market response to the collaboration announcement.

Oracle Corporation (NYSE: ORCL) has reported strong fourth-quarter fiscal 2023 earnings, with an EPS of $1.67 on revenue amounting to $13.8 billion. This exceeded the consensus EPS estimate of $1.58 on revenue of $13.73 billion. The company achieved a record-breaking annual revenue of $50 billion for fiscal year 2023.

In after-hours, $ORCL was trading at around $120.70, up $4.27 (+3.67%).

EVgo Inc. (Nasdaq: EVGO) has announced plans to incorporate North American Charging Standard (NACS) connectors into its fast charging network nationwide. 

This decision aligns with the recent announcements made by Ford Motor Company (NYSE: F) and General Motors Company (NYSE: GM) regarding their adoption of NACS by 2025. 

EVgo anticipates that these developments, along with similar initiatives by Tesla, GM, and Ford, will drive accelerated electric vehicle (EV) sales and promote growth on its network and other charging networks.

$EVGO is currently trading at $3.83 in after-hours, reflecting an increase of $0.02 (+0.52%) 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)